Inhibition of IKKβ in Enterocytes Exacerbates
Sepsis-Induced Intestinal Injury and Worsens Mortality the mechanisms underlying this survival advantage remain unclear (8, 11) .
The transcription factor nuclear factor-κB (NF-kB) regulates the transcription of multiple genes that play a central role in regulating both the cell survival and the inflammatory response (19, 20) . Under normal conditions, inactive NF-kB dimers are primarily retained in the cytoplasm via interactions with inhibitors of kB (IkB) proteins (21) . When a stimulus is received, IkB kinase (IKK), a complex comprised of two catalytic subunits, IKKα and IKKβ, and the regulatory subunit, IKKγ/NEMO, phosphorylates the IkB proteins leading to their degradation. In turn, the NF-kB dimer is free to translocate into the nucleus. In the canonical NF-kB activation pathway, this process is regulated by IKKβ (22) , which can be activated by a broad range of microbial and host-derived ligands (23) . Consequently, NF-kB binds to selective target gene promoters and induces transcriptional activation or suppression of pro-inflammatory and anti-apoptotic mediators (24) . Of note, although disruption of the IKKβ gene prevents activation of the canonical NF-kB pathway, whole animal knockouts of this gene result in embryonic lethality due to massive apoptosis in the developing liver driven by tumor necrosis factor (TNF) (25) .
NF-kB activation can play either a detrimental role or a beneficial role in the intestinal tract in response to injury and inflammation (26) . Small-molecule inhibitors of IKKβ ameliorate disease in murine models of intestinal inflammation (27, 28) . Similarly, peptides that bind IKKγ/NEMO reduce the severity of intestinal inflammation in models of colitis (29, 30) . In contrast, conditional ablation of IKKβ in intestinal epithelial cells leads to increased local inflammation and intestinal epithelial apoptosis in an acute colitis model (31) . Similarly, enterocyte-specific ablation of IKKβ leads to increased intestinal epithelial apoptosis and intestinal hyperpermeability following burn injury (32) and to increased apoptosis and mucosal injury following challenge with Clostridium difficile toxin A (33) . Intestine-specific alterations induced by NF-kB inhibition may also be counterbalanced by systemic inflammatory changes as mice with enterocyte-specific ablation of IKKβ subjected to ischemia/reperfusion injury have a marked increase in intestinal epithelial apoptosis but a simultaneous decrease in systemic inflammation (34) .
Despite the importance of NF-kB activation in regulating epithelial cell pro-inflammatory genes and intestinal epithelial cell survival, little is known about its impact on survival in critical illness. This study examined the impact of enterocytespecific deletion of IKKβ in a murine model of peritonitis on both local gut integrity and systemic inflammation and how these changes affected survival from sepsis.
MATERIALS AND METHODS

Animals
Six-to eight-week-old mice were used for all studies. Mice with selective ablation of IKKβ in intestinal epithelial cells were created via Cre/lox recombination by crossing 129/SV mice with a conditional loss-of-function IKKβ allele due to flanking exon 3 with two loxP sites (a generous gift from Dr. Michael Karin, UCSD) (34) to C57Bl/6 mice with expression of Cre recombinase under the control of the villin promoter (Jackson Laboratories, Bar Harbor, ME). Resulting offspring either lacked functional NF-kB in their intestinal epithelium (Vil-Cre/ Ikkβ f/Δ ) or had normal expression of epithelial NF-kB (Ikkβ f/Δ , functional wild type referred to hereafter as WT). Of note, mice lacking enterocyte-specific IKKβ develop normally without any apparent abnormalities of the gastrointestinal tract as long as they are kept under normal conditions (34) . All animal studies were approved by the Animal Studies Committees of Emory University School of Medicine, Washington University School of Medicine, and University of Colorado Anschutz Medical Campus and were conducted in accordance with the National Institutes of Health guidelines for the use of laboratory animals.
Sepsis Model
Peritonitis was induced in mice via cecal ligation and puncture (CLP) (35) . Under isoflurane anesthesia, a small midline abdominal incision was made, and the cecum was ligated immediately distal to the ileocecal valve. The cecum was then punctured twice with a 21-gauge needle, gently squeezed to extrude a small amount of stool, and replaced in the abdomen that was closed in layers. Sham mice were treated identically with the exception that the cecum was neither ligated nor punctured. All mice were injected subcutaneously with 1 mL of normal saline to account for insensible fluid losses that occurred during surgery. Animals were killed at 24, 48, or 72 hours (acute studies) or followed 7 days for survival.
NF-kB p65 Activation
Intestinal epithelial cells were collected by scraping the mucosa with a glass slide followed by obtaining nuclear extracts according to manufacturer's protocol (Nuclear Extract Kit, Active Motif, Carlsbad, CA). NF-kB p65 activation was determined using the TransAM NF-kB p65 Transcription Factor Assay Kit (Active Motif) according to the manufacturer's instructions.
Western blots were also performed to determine protein levels of phosphorylated NF-kB p65 in intestinal epithelial cells. Fresh mucosal scrapings were homogenized in a 5× volume of ice-cold homogenization buffer, and total protein was extracted (12) . A total of 40 µg of protein was added to an equal volume of 2× Laemmli sample buffer and heated at 95°C for 5 minutes. Samples were run on polyacrylamide gels (Bio-Rad, Hercules, CA) at 180 V for 45 minutes, and protein was transferred to Immuno-Blot polyvinylidene difluoride membranes (Bio-Rad) at 80 V for 2 hours. Membranes were blocked with 5% nonfat milk in Tris-buffered saline with 0.1% Tween 20 (Sigma, St. Louis, MO) for 1 hour at room temperature and then incubated with either rabbit polyclonal anti-NFkB p-p65 or beta-actin (1:1000; Cell Signaling Technology) overnight at 4°C. After washing, membranes were incubated for 1 hour at room temperature with horseradish peroxidase-conjugated goat antirabbit IgG (1:1000; Cell Signaling Technology). Proteins were visualized via a chemiluminescent system (Pierce, Rockford, IL) and exposed to X-ray film.
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Intestinal Epithelial Apoptosis Apoptosis was detected using two complimentary techniques: active caspase-3 staining and morphologic analysis of hematoxylin and eosin-stained sections (13, 36) . For active caspase-3, sections were incubated in 3% hydrogen peroxide for 10 minutes, heated in Antigen Decloaker (Biocare Medical, Concord, CA) for 45 minutes, blocked with 20% normal goat serum (Vector Laboratories, Burlingame, CA) and then incubated with rabbit polyclonal anti-active caspase-3 (1:100; Cell Signaling Technology, Beverly, MA) overnight at 4°C. Sections were then incubated with goat antirabbit biotinylated secondary antibody (1:200; Vector Laboratories) for 30 minutes at room temperature followed by Vectastain Elite ABC reagent (Vector Laboratories) for 30 minutes. Sections were then developed with diaminobenzidine and counterstained with hematoxylin. For morphological analysis, apoptotic cells were identified by characteristic abnormalities of cell shrinkage with nuclear condensation and fragmentation. Apoptotic intestinal epithelial cells were quantified in 100 contiguous crypts and 50 well-oriented villi per animal by an examiner blinded to specimen identity.
Morphological Analysis
Villus length was determined on hematoxylin-and-eosinstained jejunal sections by measuring the distance in micrometers from the crypt neck to the villus tip using Nikon Elements imaging software (Nikon Instruments, Melville, NY). A minimum of 12-well-oriented villi from each section were measured.
Intestinal Inflammation
Intestinal inflammation was assayed by a pathologist blinded to section identity (A.B.F.). Inflammation was scored using two independent scoring systems for intestinal inflammation (37, 38) . Sections were assessed for inflammatory infiltrate into both the lamina propria and the submucosa.
Intestinal Permeability
Permeability was measured in vivo to fluorescein isothiocyanate-conjugated dextran (FD-4, 22 mg/mL, molecular mass 4.4 kDa, Sigma) (14) . Animals were gavaged with 0.5 mL of FD-4 19 hours after laparotomy. At time of killing (5 hr after gavage), blood was collected and centrifuged at 3000 rpm at 4°C for 20 minutes. Plasma (50 μL) was mixed with an equal volume of sterile phosphate-buffered saline (pH 7.4), and the concentration of FD-4 was determined by fluorospectrometry (NanoDrop 3300, Thermo Scientific, Wilmington, DE) with an excitation wavelength of 470 nm and an emission wavelength of 515 nm using serially diluted samples as standards.
Tight Junction Expression
Quantitative real-time polymerase chain reaction (PCR) was used to evaluate gene expression of claudin-2, occludin, and ZO-1. Total RNA was isolated from whole jejunal tissue using the Illustra RNAspin Mini RNA Isolation Kit according to manufacturer's protocol (GE Healthcare, Piscataway, NJ), and complementary DNA was synthesized from 0.5 μg of total RNA. Gene expression was detected using predeveloped TaqMan primers and probes (Applied Biosystems, Foster City, CA) and run on an ABI 7900HT Sequence Detection System (Applied Biosystems). All samples were run in duplicate and normalized to expression of the endogenous control, glyceraldehyde-3-phosphate (GAPDH; Applied Biosystems). Relative quantification of PCR products were based on the value differences between the target gene and the GAPDH using the comparative C T method.
Cellular localization of claudin-2 was also evaluated by fluorescent immunohistochemistry. Intestinal sections were incubated in 3% hydrogen peroxide for 10 minutes, heated in Antigen Decloaker (Biocare Medical) for 45 minutes for antigen retrieval, blocked with 20% normal goat serum (Vector Laboratories) and incubated for 3 hours at room temperature with rabbit polyclonal anticlaudin-2 (1:200; Abcam, Cambridge, MA). Slides were then incubated in goat antirabbit Alexa 594-conjugated secondary antibody (1:200, Invitrogen) for 30 minutes at room temperature, and diamidino-2-phenylindole was used to fluorescently label nuclei.
Cytokine Levels
Blood was harvested at time of killing, and serum was obtained by centrifugation at 5,000 rpm for 5 minutes in serum separator tubes and stored at −80°C until further use. Serum cytokine levels of IL-1β, IL-6, IL-10, IL-12, IL-13, interferon-γ, TNF, granulocyte colony-stimulating factor, and monocyte chemoattractant protein-1 (MCP-1) were measured using a multiplex cytokine assay (Bio-Rad, Hercules, CA) according to manufacturer's instructions. All samples were run in duplicate.
Cultures
Blood was serially diluted in sterile normal saline and cultured on sheep blood agar plates. Additionally, a piece of liver and two mesenteric lymph nodes were harvested and weighed and then ground with disposable tissue grinders and suspended in 100 μL of sterile normal saline. Each sample was incubated overnight at 37°C, and colony counts were enumerated. Colony counts were expressed as CFU/mL of fluid and then converted to a logarithmic scale for statistical analysis (39, 40) .
Monoclonal Anti-TNF Antibody
Mice were given a single intraperitoneal injection of 300 µg of monoclonal anti-TNF antibody TN3 19.12 (a generous gift from Dr. Robert Schreiber, Washington University) or an equivalent volume of isotype control 3 hours prior to CLP. Of note, experiments with anti-TNF were performed at the same time as other experiments but are presented separately for ease of presentation.
Statistics
Continuous data sets were tested for Gaussian distribution using the D'Agostino-Pearson omnibus normality test. If data were found to have Gaussian distributions, multiple-group comparisons were performed using one-way analysis of variance followed by the Newman-Keuls posttest. If data were found to have non-Gaussian distributions, multiple-group www.ccmjournal.org
October 2013 • Volume 41 • Number 10 comparisons were performed using the Kruskal-Wallis nonparametric one-way analysis of variance by ranks followed by the Dunns posttest. Survival studies were analyzed using the log-rank test. Data were analyzed using the statistical software program Prism 4.0 (GraphPad Software, San Diego, CA) and are reported as mean ± standard error mean. A p value of less than 0.05 was considered statistically significant.
RESULTS
In all experiments, comparisons were made between 1) WT sham and septic mice, 2) Vil-Cre/Ikkβ f/Δ sham and septic mice, and 3) WT and Vil-Cre/Ikkβ f/Δ septic mice. Unless otherwise specified, animals were killed 24 hours after the onset of sepsis.
Sepsis-Induced NF-kB Activation in the Intestinal
Epithelium Is Abrogated in Vil-Cre/Ikkβ f/Δ Mice To verify that NF-kB activation in the intestinal epithelium was diminished by selective enterocyte ablation of IKKβ, NF-kB p65 activation was compared between septic WT and Vil-Cre/Ikkβ f/Δ mice (Fig. 1A) . Activation of NF-kB p65 in the intestinal epithelium was abrogated by selective ablation of IKKβ in the intestinal epithelium 24 hours after CLP. A similar pattern was noted for intestinal epithelial expression of phosphorylated NF-kB p65, which was significantly decreased in septic Vil-Cre/Ikkβ f/Δ mice in both sham and septic mice (Fig. 1, B and C) .
Enterocyte NF-kB Protects t he Intestinal Ipithelium From Sepsis-Induced Gut Damage
To determine whether enterocyte NF-kB altered sepsisinduced changes in gut integrity, villus length and intestinal epithelial apoptosis were measured in sham and septic WT and Vil-Cre/Ikkβ f/Δ mice. Septic WT mice exhibited a 24% decrease in villus length compared with sham mice, whereas septic Vil-Cre/Ikkβ f/Δ mice had worsened villus atrophy with a 22% further decrease in villus length compared with septic WT mice (Fig. 2) .
Sepsis also induced a significant increase in intestinal epithelial apoptosis in both the crypts and villi of WT mice as measured by the number of apoptotic cells per 100 crypts (Fig. 3, A and B) and per 50 villi (Fig. 3, C and D) by either active caspase-3 staining (Fig. 3E) or hematoxylin and eosin staining. Similar to villus length, sepsis-induced apoptosis was further exacerbated in the crypt and villus epithelium in septic Vil-Cre/Ikkβ f/Δ mice compared with septic WT mice. In contrast, there was minimal inflammatory infiltration in either the lamina propria or the submucosa in either septic WT or VilCre/Ikkβ f/Δ mice.
Enterocyte NF-kB Protects the Intestinal Epithelium From Sepsis-Induced Intestinal Barrier Dysfunction
Because sepsis-induced intestinal injury was increased in mice lacking functional enterocyte NF-kB, intestinal barrier function was assayed in these mice. Sepsis induced a 1.7-fold increase in intestinal permeability in WT mice compared with sham mice as measured by the appearance of FD-4 in the bloodstream, whereas septic Vil-Cre/Ikkβ f/Δ mice had worsened intestinal hyperpermeability with a 34% increase in FD-4 appearance compared with septic WT mice (Fig. 4A) .
To determine whether alterations in tight junction proteins contributed to intestinal barrier dysfunction, claudin-2, occludin, and ZO-1 expression in the intestinal epithelium were evaluated by real-time PCR. Intestinal gene expression of claudin-2 was increased in septic WT mice compared with sham mice and further increased by 43% in septic Vil-Cre/ Ikkβ f/Δ mice (Fig. 4B) . Claudin-2 localization was then analyzed via fluorescent immunohistochemistry (Fig. 4C) . Septic WT mice exhibited increased expression of claudin-2 in the crypts with minimal expression in the villus epithelium compared with sham mice. In contrast, septic Vil-Cre/Ikkβ f/Δ mice exhibited increased expression in the crypts, as well as a change in subcellular localization with strong localization along the apical membrane of the villi. In contrast, occludin and ZO-1 expressions were similar among all groups 24-hour post-CLP (Fig. 4, D and E) , and their subcellular localization was not different among groups (data not shown).
The Impact of Enterocyte NF-kB on Cytokines and Bacteremia
To determine whether the lack of functional enterocyte NF-kB altered the systemic inflammatory response to sepsis, serum cytokine levels were assayed in sham and septic WT and Vil-Cre/Ikkβ f/Δ mice at 24 hours ( Table 1) . The pro-inflammatory cytokines IL-6 and MCP-1, as well as the anti-inflammatory cytokine IL-10, were significantly increased in serum 24 hours after the onset of sepsis in WT mice. Additionally, serum MCP-1 and IL-10 were higher in septic Vil-Cre/Ikkβ f/Δ mice compared with septic WT mice. No differences were seen in cytokine levels among these animals at 48 mice were subjected to CLP and followed 7 days for survival (Fig. 5) . Septic WT mice had a 47% 7-day mortality, whereas septic Vil-Cre/ Ikkβ f/Δ mice had an 80% mortality (p < 0.05). All sham mice survived their operation.
Sepsis-Induced Hyperpermeability and Intestinal Apoptosis Are Mediated by TNF
The pro-inflammatory cytokine TNF is a key mediator of both intestinal barrier dysfunction and sepsis-induced inflammation. CLP increased levels of serum TNF in both WT and Vil-Cre/Ikkβ f/Δ mice, but enterocyte NF-kB did not affect TNF levels as TNF levels were similar in septic WT and VilCre/Ikkβ f/Δ mice (Fig. 6A) as were TNF levels in the jejunual epithelium by western blot (data not shown). To determine whether sepsis-induced intestinal hyperpermeability is mediated by TNF, WT and Vil-Cre/Ikkβ f/Δ mice animals were treated with anti-TNF antibody 3 hours prior to CLP, which completely blocks the increase in serum TNF induced by CLP (Fig. 6A) . Neutralizing TNF prevented sepsis-induced intestinal hyperpermeability (Fig. 1B) , suggesting TNF is a key mediator of barrier dysfunction in sepsis. A similar decrease in intestinal hypermeability was seen in septic Vil-Cre/Ikkβ f/Δ mice following administration of anti-TNF antibody (Fig. 6B) . To determine whether intestinal hyperpermeability correlated to severity of bacteremia, blood cultures were also obtained in a different set of animals subjected to the same insults. Anti-TNF administration led to a nonsignificant decrease in bacteremia in WT mice, consistent with the decrease in permeability (Fig.  6C) . A further decrease in bacteremia was observed in septic Vil-Cre/Ikkβ f/Δ mice given anti-TNF antibody (Fig. 6C) . Of note, changes in claudin-2 gene expression mirrored those of intestinal permeability (Fig. 6D) , and subcellular localization f/Δ septic mice treated with anti-TNF antibody (data not shown). Anti-TNF antibody had no effect on intestinal expression of either occludin or ZO-1 (data not shown).
The impact of TNF neutralization on sepsis-induced gut epithelial apoptosis was also assayed. Similar to permeability and claudin-2 gene expression, anti-TNF antibody significantly decreased sepsis-induced intestinal epithelial apoptosis in the crypts and villi (Fig. 6E) , A similar decrease in intestinal apoptosis was seen in septic Vil-Cre/Ikkβ f/Δ mice following administration of anti-TNF antibody (Fig. 6E) .
To determine the impact of TNF on mortality, anti-TNF antibodies were given to WT and Vil-Cre/Ikkβ f/Δ mice subjected to CLP, which were followed 7 days for survival. Anti-TNF treatment significantly improved mortality in WT septic mice (Fig. 6F) . A similar improvement in mortality was seen in septic Vil-Cre/Ikkβ f/Δ mice following administration of anti-TNF antibody because mortality in septic Vil-Cre/Ikkβ f/Δ mice was 80% (Fig. 5) , whereas mortality in septic Vil-Cre/Ikkβ f/Δ mice given anti-TNF was 25% (Fig. 6E) .
DISCUSSION
This study demonstrates that inhibition of NF-kB in enterocytes exacerbates sepsis-induced intestinal injury and worsens mortality in mice subjected to CLP. Although NF-kB inhibition has been proposed as a therapeutic approach for sepsis (41) , findings in gene-targeted mice and studies with pharmacological inhibitors indicate that NF-kB regulates both protective and destructive responses (42) (43) (44) . As such, the net effects of NF-kB inhibition need to be evaluated carefully.
By isolating the enterocyte-specific effects of NF-kB, this study expands our understanding of the role the intestine plays as the "motor" of the systemic inflammatory response syndrome. One possible way enterocyte-specific NF-kB apears to be protective in sepsis is by abrogating intestinal epithelial apoptosis. It is known that NF-kB is a critical regulator of the transcriptional activation of a multitude of genes involved in apoptosis (32) , and this could profoundly influence mucosal repair in sepsis. For example, NF-kB can up-regulate antiapoptotic molecules such as c-FLIP, c-IAPs, and anti-apoptotic Bcl-2 family members (24) . Consistent with this, failure to activate enterocyte NF-kB resulted in exacerbated intestinal epithelial apoptosis following CLP. Our results are consistent with previous studies of mice that lack enterocyte IKKβ exhibit showing marked increases in intestinal epithelial apoptosis following radiation (45), C. difficile toxin A (33), and thermal injury (32) .
Intestinal barrier function was dependent, at least in part, on enterocyte NF-kB in this study because intestinal hypermpermeability was worsened following CLP in Vil-Cre/Ikkβ f/Δ mice www.ccmjournal.org e281 compared with WT mice. It is possible that this was secondary to the up-regulation in sepsis-induced apoptosis seen in VilCre/Ikkβ f/Δ mice, as there is data suggesting that intestinal permeability is dependent on apoptosis in models of critical illness (46, 47) . The increase in sepsis-induced hyperpermeability was associated with an increase in claudin-2. This pore-forming protein is associated with increased paracellular permeability and has previously been shown to be up-regulated in the inflamed mucosa of patients with inflammatory bowel disease (48, 49) . Similarly, previous data from our laboratory demonstrated that claudin-2 is significantly increased in the intestine following CLP (14) . The observation that claudin-2 is increased and changes subcellular localization after the onset of sepsis but is exacerbated following CLP in Vil-Cre/Ikkβ f/Δ mice suggests that its regulation in the intestinal tight junction is at least partially NF-kB dependent. In contrast, neither occludin nor ZO-1 was affected by CLP or enterocyte NF-kB in this study.
Although enterocyte NF-kB plays a protective role in the intestine following sepsis, this does not mean that its effects are globally protective. For example, in mice subjected to ischemia/reperfusion, enterocyte NF-kB inhibition induces a marked increase in intestinal epithelial apoptosis (as is seen following CLP) but simultaneously leads to a marked decrease in systemic inflammation (34) . The functional significance of these findings in ischemia/reperfusion is unclear because animals were not followed for survival. However, altering the host inflammatory response might be expected to have a profound impact on mortality, although whether this would be beneficial or detrimental is likely dependent on the severity of the proand anti-inflammatory response, as well as the timing of the response (50-53). As a surrogate for the systemic inflammatory response, serum cytokine levels were, therefore, examined following CLP. As might be expected, sepsis induced a significant increase in both pro-inflammatory IL-6 and MCP-1, as well as anti-inflammatory IL-10 (54). However, enterocyte NF-kB generally did not alter systemic cytokines 24, 48, or 72 hours following CLP because there were no differences in cytokine levels between Vil-Cre/Ikkβ f/Δ and WT mice except . Septic WT mice exhibited increased permeability compared with shams, whereas septic Vil-Cre/Ikkβ f/Δ mice had a further increase in intestinal permeability compared with septic WT mice. n = 9-12 per group. Gene expression of claudin-2 (B) was then evaluated by quantitative reverse transcriptase-polymerase chain reaction. Claudin-2 levels were increased in septic WT mice compared to shams, whereas septic Vil-Cre/Ikkβ f/Δ mice had a further increase in claudin-2 expression. n = 8-14 per group. Localization of claudin-2 was evaluated by fluorescent immunohistochemistry (C). Compared with sham WT and septic Vil-Cre/Ikkβ f/Δ mice, which had minimal staining (not shown), claudin-2 expression was increased in septic WT mice and localized predominantly in the crypts. In contrast, septic Vil-Cre/Ikkβ f/Δ mice exhibited increased claudin-2 that was localized along the apical membrane of the villi, as well as in the crypts. Representative images for each group are shown. Magnification ×20. Gene expression of occludin (D) and ZO-1 (E) was also evaluated by quantitative reverse transcriptase-polymerase chain reaction. No differences were detected in either occludin or ZO-1, independent of whether an animal was subjected to cecal ligation and puncture or had enterocyte NF-kB. n = 8-14 per group. mice at 24 hours. Although this differs from results seen in ischemia/reperfusion, this may be explained by differences in when cytokines were measured (4 hr after ischemia/reperfusion, 24-72 hr after CLP) (34) . Additionally, no differences in bacteremia were noted between Vil-Cre/Ikkβ f/Δ and WT septic mice. These results are consistent with findings in mice lacking the cRel subunit of NF-kB, in which there are no differences in bacterial counts in the liver, spleen, or blood compared with WT mice after CLP (55) . Taken together, these data suggest that the increased mortality observed in mice that lack functional enterocyte NF-kB is not a result of increased systemic inflammation or impaired pathogen clearance. Instead, sepsisinduced alterations in intestinal integrity that are dependent on enterocyte NF-kB may have played a role in mediating the worsened mortality in Vil-Cre/Ikkβ f/Δ septic mice.
The pro-inflammatory cytokine TNF is involved in both the NF-kB signaling and the pathophysiology of sepsis. TNF binds to TNFR1, which induces NF-kB signaling, MAPK pro-inflammatory signaling, and apoptosis. However, NF-kB activation protects cells from TNFR1-mediated apoptosis by inducing anti-apoptotic proteins. As such, NF-kB activation determines cellular fate following TNF binding, with induction of proinflammatory signals in NF-kB-competent cells but induction of death of NF-kB-deficient cells (26, 56) . In addition to its pro-apoptotic role in the intestinal epithelium, TNF is a key mediator of inflammation-induced barrier dysfunction and causes a time-and dose-dependent increase in the expression of claudin-2 in human intestinal epithelial cell monolayers, leading to increased paracellular permeability (57) .
In light of the fact that 1) NF-kB signaling can be induced by TNF and 2) the critical role TNF plays in sepsis, TNF blockade was, therefore, examined in septic Vil-Cre/Ikkβ f/Δ and WT mice. The results indicated that sepsis-induced changes in intestinal epithelial apoptosis, permeability, bacteremia, and mortality were all mediated by TNF as each of these variables was partially or fully normalized by giving mice anti-TNF antibodies as shown in Figure 1 . The results also demonstrated that mice that lack enterocyte NF-kB had increased gut apoptosis, permeability, and mortality compared with WT animals (Figs 2-5 ). To study a potential Figure 5 . Sepsis-induced mortality is higher in mice lacking functional enterocyte NF-kB. Mice were subjected to cecal ligation and puncture and followed 7 days for survival. Septic mice lacking functional enterocyte NF-kB (Vil-Cre/Ikkβ f/Δ mice) had worsened mortality compared with septic wild-type mice (p < 0.05). All sham animals survived.
www.ccmjournal.org e283 relationship among these findings, we examined apoptosis, permeability, bacteremia, and mortality in Vil-Cre/Ikkβ f/Δ mice treated with or without anti-TNF. The results showed that apoptosis, permeability, and mortality were lower in Vil-Cre/ Ikkβ f/Δ mice that were treated with anti-TNF and that TNF blockade decreased bacteremia in these animals. Together, these data indicate that 1) enterocyte NF-kB plays a critical role in mediating intestinal integrity and mortality in the murine model of CLP; 2) TNF also plays a critical role in mediating intestinal integrity and mortality in the murine model of CLP; and 3) all variables worsened by the absence of NF-kB were improved by administering anti-TNF antibody.
This study has a number of limitations. Although serum cytokines were used as a surrogate of the systemic inflammatory response, absolute cytokine levels frequently do not correlate to inflammatory status on a tissue level, and performing ex vivo studies on stimulated leukocytes may have given a more complete picture of systemic inflammation. Additionally, we examined RNA on tight junction proteins from whole jejunal tissue rather than jejunal mucosal scrapings. Vil-Cre/Ikkβ f/Δ mice also have a lifelong genetic deletion in IKKβ. Although these animals have no gross phenotypic abnormalities in their intestinal tract under basal conditions, there may be unknown long-standing compensatory abnormalities induced by deletion of enterocyte NF-kB, which predisposed animals to have a negative outcome when subjected to the acute septic stress induced by CLP.
Although we wish to emphasize that the purpose behind performing the anti-TNF experiments was to determine whether the impact of enterocyte NF-kB on gut integrity and mortality was TNF-dependent (rather than examining the effect of anti-TNF in isolation), there were also a number of limitations related to our studies using anti-TNF. First, we found that anti-TNF significantly improved survival in mice subjected to Figure 6 . Sepsis-induced alterations in intestinal integrity, permeability, and mortality are dependent on tumor necrosis factor (TNF). Sepsis-induced increases in serum TNF were completely blocked following TNF neutralization. n = 8-18 per group (A). Intestinal permeability was lower in septic (wild-type) WT mice following anti-TNF antibody and in septic Vil-Cre/Ikkβ f/Δ mice following anti-TNF antibody; however, intestinal permeability was not different between Vil-Cre/Ikkβ f/Δ and WT mice following TNF neutralization. n = 8-18 per group (B). Bacteremia was decreased in septic WT mice following anti-TNF antibody and was further decreased in Vil-Cre/Ikkβ f/Δ mice following TNF neutralization. n = 8-18 per group (C). Claudin-2 expression was lower in septic WT mice following anti-TNF antibody; however, claudin-2 expression was not different between Vil-Cre/Ikkβ f/Δ and WT mice following TNF neutralization. n = 8-14 per group (D). Intestinal epithelial apoptosis was lower in septic WT mice treated with anti-TNF antibody and in septic Vil-Cre/Ikkβ f/Δ mice following anti-TNF antibody; however, apoptosis was not different between Vil-Cre/Ikkβ f/Δ and WT mice following TNF neutralization. n = 5-12 per group (E). Anti-TNF treatment significantly improved mortality in both Vil-Cre/Ikkβ f/Δ and WT mice compared with untreated groups; however, there were no significant differences in the mortality between Vil-Cre/Ikkβ f/Δ and WT mice following TNF neutralization (F).
CLP. These findings are somewhat at odds with 12 human trials on over 6,000 patients suggesting that anti-TNF has limited impact on survival (58), although TNF blockade appears to be more efficacioius in sicker patients. Additionally, there have been at least 23 studies examining the impact of TNF blockade on mortality from CLP, of which 41% showed benefit by inhibiting TNF and which globally showed neither benefit nor harm (59) . Although our findings are, thus, consistent with some (but not all) prior preclinical studies, their clinical relevance is unclear. Additionally, although our studies were done in a relatively highmortality model (where anti-TNF has been shown to have the most clinical effiacy in patients in meta-analyses), the impact of the agent was much greater in mice than is seen in patients. It should also be noted that the levels of systemic TNF we identified in septic mice were significantly higher than those found in patients 24 hours after they were diagnosed with peritonitis (60) . This may, in part, be related to the amount of cecum ligated as there are widely varying levels of TNF identified in the bloodstream of septic animals based on this variable (61); however, this may lessen the clinical relevance of our findings. Despite these limitations, this study demonstrates that activation of enterocyte NF-kB has a protective role in sepsis-induced intestinal injury. Although activation of NF-kB induces multiple proteins that can be either adaptive or maladaptive, enterocyte NF-kB appears beneficial, as mortality is increased in its absence. These results have implications for the potential therapeutic use of IKKβ/NF-kB inhibitors and raise concerns about prolonged inhibition of this pathway.
